A detailed history of Schonfeld Strategic Advisors LLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 212,250 shares of CDMO stock, worth $2.62 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
212,250
Previous 553,953 61.68%
Holding current value
$2.62 Million
Previous $3.96 Million 38.94%
% of portfolio
0.02%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.7 - $12.45 $2.29 Million - $4.25 Million
-341,703 Reduced 61.68%
212,250 $2.42 Million
Q2 2024

Aug 14, 2024

BUY
$6.34 - $9.28 $338,879 - $496,025
53,451 Added 10.68%
553,953 $3.96 Million
Q1 2024

May 15, 2024

BUY
$5.86 - $8.79 $2.79 Million - $4.18 Million
476,009 Added 1943.45%
500,502 $3.35 Million
Q4 2023

Feb 14, 2024

SELL
$4.64 - $9.56 $128,797 - $265,366
-27,758 Reduced 53.12%
24,493 $159,000
Q3 2023

Nov 14, 2023

SELL
$9.4 - $14.04 $122,876 - $183,530
-13,072 Reduced 20.01%
52,251 $493,000
Q2 2023

Aug 14, 2023

SELL
$12.96 - $20.93 $3.34 Million - $5.39 Million
-257,483 Reduced 79.76%
65,323 $912,000
Q1 2023

May 15, 2023

BUY
$13.48 - $18.79 $1.37 Million - $1.91 Million
101,606 Added 45.93%
322,806 $6.06 Million
Q4 2022

Feb 14, 2023

BUY
$12.61 - $18.74 $478,410 - $710,976
37,939 Added 20.7%
221,200 $3.05 Million
Q3 2022

Nov 14, 2022

BUY
$15.33 - $20.36 $1.28 Million - $1.7 Million
83,617 Added 83.92%
183,261 $3.5 Million
Q2 2022

Aug 15, 2022

BUY
$11.63 - $21.55 $814,611 - $1.51 Million
70,044 Added 236.64%
99,644 $1.52 Million
Q1 2022

May 16, 2022

SELL
$16.63 - $27.73 $395,794 - $659,974
-23,800 Reduced 44.57%
29,600 $603,000
Q4 2021

Feb 14, 2022

SELL
$20.7 - $34.18 $386,841 - $638,755
-18,688 Reduced 25.92%
53,400 $1.56 Million
Q3 2021

Nov 16, 2021

SELL
$19.05 - $28.32 $407,898 - $606,387
-21,412 Reduced 22.9%
72,088 $1.56 Million
Q2 2021

Aug 16, 2021

SELL
$18.93 - $25.65 $2.99 Million - $4.05 Million
-158,000 Reduced 62.82%
93,500 $2.4 Million
Q1 2021

May 17, 2021

BUY
$11.86 - $21.77 $1.75 Million - $3.22 Million
147,800 Added 142.53%
251,500 $4.59 Million
Q4 2020

Feb 16, 2021

BUY
$7.25 - $11.76 $117,450 - $190,512
16,200 Added 18.51%
103,700 $1.2 Million
Q3 2020

Nov 16, 2020

BUY
$6.53 - $8.6 $314,093 - $413,660
48,100 Added 122.08%
87,500 $1,000
Q2 2020

Aug 14, 2020

BUY
$4.11 - $6.78 $161,934 - $267,132
39,400 New
39,400 $259,000
Q1 2020

May 15, 2020

SELL
$3.15 - $7.39 $90,090 - $211,354
-28,600 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$5.01 - $8.16 $121,242 - $197,472
-24,200 Reduced 45.83%
28,600 $219,000
Q3 2019

Nov 14, 2019

BUY
$5.07 - $7.08 $267,696 - $373,824
52,800 New
52,800 $280,000
Q2 2019

Aug 14, 2019

SELL
$3.43 - $5.6 $1.52 Million - $2.48 Million
-442,600 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$3.56 - $4.82 $812,036 - $1.1 Million
-228,100 Reduced 34.01%
442,600 $1.88 Million
Q4 2018

Feb 14, 2019

SELL
$4.04 - $6.75 $84,840 - $141,750
-21,000 Reduced 3.04%
670,700 $2.75 Million
Q3 2018

Nov 14, 2018

BUY
$4.28 - $7.32 $2.75 Million - $4.7 Million
641,700 Added 1283.4%
691,700 $4.75 Million
Q2 2018

Aug 14, 2018

BUY
$3.1 - $3.93 $155,000 - $196,500
50,000 New
50,000 $196,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $767M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.